Jul. 16 at 5:53 PM
$RPTX Under the terms of the agreement, Repare will receive a
$10 million upfront payment, and is eligible to receive up to
$257 million in potential clinical, regulatory, commercial and sales milestones, including up to
$5 million in potential near-term payments, and single-digit royalties on global net sales.
$IOVA $EDIT
